
Levitrap 750mg Tablet
Marketer
Emocare
Salt Composition
Levetiracetam (750mg)
Overview Levitrap 750mg Tablet
Epileptic seizures are managed with the anticonvulsant Levexa 750mg tablets. This medication, used either independently or in conjunction with other therapies, helps control seizures by suppressing abnormal brain electrical activity. Consistent daily dosing, ideally at the same time, maximizes effectiveness, regardless of food intake. Dosage is individualized based on patient response and condition, determined by your physician. Long-term use is generally recommended; discontinuation or missed doses may exacerbate seizures, thus adherence to your doctor's prescribed regimen is crucial, even during symptom remission. Common side effects, often diminishing after initial weeks, include headache, irritability, drowsiness, behavioral shifts (including aggression), and reduced appetite. While most side effects are mild, some may be severe, and the potential for suicidal ideation requires close monitoring. Report any worsening mood changes to your doctor immediately. Prior to commencing treatment, inform your physician of any pre-existing kidney disease, depression, suicidal tendencies, or pregnancy/breastfeeding plans. Regular blood tests to assess kidney function may be recommended during treatment.
Uses of Levitrap 750mg Tablet
Managing Epileptic Seizures
Major Benefits of Levitrap 750mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the 750mg Levitrap tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with or precede meals; however, consistent timing is recommended.
Common Side effects of Levitrap 750mg Tablet:
- Sleepiness
- Dizziness
- Fatigue
- Headache
- Decreased appetite
- Behavioral changes
- Aggressive behavior
- Irritation
- Agitation
- Nasal congestion (stuffy nose)
- Infection
- Convulsion
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nausea
- Tremors
- Vertigo
- Lethargy
How to use Levitrap 750mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 750mg Levitrap tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
How Levitrap 750mg Tablet works:
Epilepsy treatment, Levitrap 750mg tablets, targets nerve cell activity. By binding to SV2A receptors, it inhibits aberrant neuronal firing, thus preventing seizure propagation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Levitrap 750mg Tablet with alcohol is strongly discouraged due to safety concerns.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Levitrap 750mg tablets is considered safe. Research indicates minimal to no fetal risk.
Breast feedingSAFE IF PRESCRIBED
Use of 750mg Levitrap tablets during breastfeeding is likely safe. Available human data indicates minimal risk to the infant. Observe the infant for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Taking a 750mg Levitrap tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use 750mg Levitrap tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of the 750mg Levitrap tablet in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended. A reduced dosage might be preferable for individuals with advanced liver impairment.
What if you forget to take Levitrap 750mg Tablet :
Should you forget a Levitrap 750mg Tablet dose, take it immediately if you remember. However, near the time for your next dose, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Levitrap 750mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrrolidinone-Acetamide Hybrid |
| Developing Habits | No. |
| Type of Therapy | Neuroscience Central Nervous System |
| Actions | AED: A protein ligand in synaptic vesicle 2 |
